Instruction for use: Otipax

ATX Code S02DA30 Analgesics and anesthetics in combination

Pharmacological groups

Local anesthetics in combination

NSAIDs - Pyrazolones in combinations

Nosological classification (ICD-10)

H66 Suppurative and unspecified otitis media

Bacterial ear infections, Inflammation of the middle ear, Infections of the upper respiratory tract, Infectious-inflammatory diseases of ENT organs, Infectious-inflammatory diseases of upper respiratory tract, Infectious-inflammatory diseases of the ear, Infectious diseases of ENT organs with marked pain syndrome, ear Infection, Otitis media infection, Persistent inflammation of the middle ear in children, Ear pain of otitis

Composition and form of release

100 g of ear drops contain phenazone 4 g and lidocaine hydrochloride 1 g, as well as sodium thiosulfate, alcohol 95%, glycerin in equal parts up to 100 g; in bottles of 16 grams, in a cardboard box 1 bottle.

pharmachologic effect

Pharmacological action - anti-inflammatory, local anesthetic, antiseptic.

Phenazone blocks cyclooxygenase and inhibits the biosynthesis of "anti-inflammatory" PG. Lidocaine, due to antagonism with sodium and calcium ions at the level of the nerve fiber membrane, disrupts perception and pain impulse.

Indications

Otitis: acute middle, postgripposis, barotraumatic, etc.

Contraindications

Hypersensitivity, mechanical damage to the tympanic membrane, allergic reaction to lidocaine.

Side effects

Allergic reactions.

Dosing and Administration

Bury in the external ear canal for 4 drops 2-3 times a day for 10 days (no more).

storage conditions

At temperatures below 30 ° C (do not freeze).

Keep out of the reach of children.

Shelf life

5 years.

Do not use after the expiry date printed on the package.